Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
biosimilar |
| gptkbp:activeIngredient |
bevacizumab-awwb
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2017-09-14 |
| gptkbp:ATCCode |
L01XC07
|
| gptkbp:brand |
gptkb:bevacizumab
|
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
solution for infusion
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mvasi
|
| gptkbp:indication |
gptkb:non-small_cell_lung_cancer
gptkb:cancer gptkb:fallopian_tube_cancer gptkb:glioblastoma colorectal cancer renal cell carcinoma peritoneal cancer |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Amgen
|
| gptkbp:mechanismOfAction |
VEGF inhibitor
|
| gptkbp:product |
gptkb:Avastin
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:bfsParent |
gptkb:bevacizumab
|
| gptkbp:bfsLayer |
6
|